Familial and second lung cancers: A nation-wide epidemiologic study from Sweden

Lung Cancer

Volumn 39, Issue 3, 2003, Pages 255-263

  Li, Xinjun ^a   Hemminki, Kari ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adenocarcinoma; Familial risk; Hereditary factors; Lung neoplasms; Second cancer; Squamous cell carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CHILD; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; HODGKIN DISEASE; HUMAN; INFANT; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SECOND CANCER; SEX DIFFERENCE; SMOKING HABIT; SOCIAL ASPECT; SQUAMOUS CELL CARCINOMA; SWEDEN;

EID: 0037373666     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00535-4     Document Type: Article

References (39)

1. IARC Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC; 1999.
2. Gsur A., Haidinger G., Hollaus P., et al. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk. Anticancer Res. 21:2001;2237-2242.
3. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343:2000;78-85.
4. Hemminki K., Lonnstedt I., Vaittinen P., Lichtenstein P. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet. Epidem. 20:2001;107-116.
5. Czene K., Lichtenstein P., Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer. 99:2002;260-266.
6. Hemminki K., Jiang Y. Cancer risks among long-standing spouses. Br. J. Cancer. 86:2002;1737-1740.
7. Dong C., Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int. J. Cancer. 92:2001;144-150.
8. Goldgar D.E., Easton D.F., Cannon-Albright L.A., Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. 86:1994;1600-1608.
9. Sellers T.A., Elston R.C., Atwood L.D., Rothschild H. Lung cancer histologic type and family history of cancer. Cancer. 69:1992;86-91.
10. Mayne S.T., Buenconsejo J., Janerich D.T. Familial cancer history and lung cancer risk in United States nonsmoking men and women. Cancer Epidem. Biomark. Prev. 8:1999;1065-1069.
11. Bromen K., Pohlabeln H., Jahn I., Ahrens W., Jockel K.H. Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am. J. Epidem. 152:2000;497-505.
12. Lindor N.M., Greene M.H. The concise handbook of family cancer syndromes. Mayo familial cancer program. J. Natl. Cancer Inst. 90:1998;1039-1071.
13. Nelkin B.D., Mabry M., Baylin S.B. Lung cancer. Bert V., Kenneth W.K. The genetic basis of human cancer. 1998;McGraw-Hill.
14. Hemminki K., Li X., Plna K., Granstrom C., Vaittinen P. The nation-wide Swedish family-cancer database: updated structure and familial rates. Acta Oncol. 40:2001;772-777.
15. Dong C., Hemminki K. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int. J. Cancer. 92:2001;883-887.
16. Hemminki K., Vaittinen P., Kyyronen P. Age-specific familial risks in common cancers of the offspring. Int. J. Cancer. 78:1998;172-175.
17. Hemminki K., Vaittinen P., Kyyronen P. Modification of cancer risk in offspring by parental cancer (Sweden). Cancer Causes Control. 10:1999;125-129.
18. Hemminki K. Genetic epidemiology - science and ethics on familial cancers. Acta Oncol. 40:2001;439-444.
19. Centre for Epidemiology Cancer incidence in Sweden 1998. Stockholm: The National Board of Health and Welfare; 2000.
20. Ekstrom A.M., Signorello L.B., Hansson L.E., Bergstrom R., Lindgren A., Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J. Natl. Cancer Inst. 91:1999;786-790.
21. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ 1994; 128: 1-302.
22. Miettinen O.S. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am. J. Epidem. 99:1974;325-332.
23. Rothman K., Greenland S. Modern epidemiology. 1998;Lippincott-Raven, Philadelphia.
24. Dong C., Hemminki K. Second primary neoplasms in 633964 cancer patients in Sweden, 1958-1996. Int. J. Cancer. 93:2001;155-161.
25. Hemminki K, Li X. Familial risk of cancer by site and histopathology. Int. J. Cancer, 2003;103:105-9.
26. Li X., Mutanen P., Hemminki K. Gender-specific incidence trends in lung cancer by histological type in Sweden, 1958-1996. Eur. J. Cancer Prev. 10:2001;227-235.
27. Thun M.J., Lally C.A., Flannery J.T., Calle E.E., Flanders W.D., Heath C.W. Jr. Cigarette smoking and changes in the histopathology of lung cancer. J. Natl. Cancer Inst. 89:1997;1580-1586.
28. Wingo P.A., Ries L.A., Giovino G.A., et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst. 91:1999;675-690.
29. Hemminki K., Li X., Czene K. Cancer risks in first-generation immigrants to Sweden. Int. J. Cancer. 99:2002;218-228.
30. IARC GLOBOCAN 2000. Cancer incidence, Mortality and prevalence worldwide. Lyon: IARC Press; 2001.
31. Wood M.E., Kelly K., Mullineaux L.G., Bunn P.A. Jr. The inherited nature of lung cancer: a pilot study. Lung Cancer. 30:2000;135-144.
32. Agudo A., Ahrens W., Benhamou E., et al. Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe. Int. J. Cancer. 88:2000;820-827.
33. IARC human papillomaviruses, IARC monographs on the carcinogenic risk to humans. Lyon: IARC; 1995.
34. Hemminki K., Jiang Y. Life style and cancer: effect of divorce. Int. J. Cancer. 98:2002;316-319.
35. Frödin J.-E., Ericsson J., Barlow L. Multiple primary malignant tumors in a national cancer registry. Reliability of reporting. Acta Oncol. 36:1997;465-469.
36. Metayer C., Lynch C., Clarke E., et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J. Clin. Oncol. 18:2000;2435-2443.
37. Swerdlow A., Barber J., Hudson G., et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J. Clin. Oncol. 18:2000;498-509.
38. Birkeland S.A., Storm H.H., Lamm L.U., et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int. J. Cancer. 60:1995;183-189.
39. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Human immunodeficiency viruses and human T-cell lymphotrophic viruses. Lyon: IARC; 1996.